Daniel D.

Daniel D. is an expert scientist with experience in particle identification in (bio)pharmaceuticals and virus-based ATMP formulation development. Prior to their current position at Coriolis Pharma, Daniel worked as a scientist at the Robert Koch Institute where Daniel was involved in the development of a novel influenza virus peptide subtyping assay. Daniel D. holds a Dr. rer. nat. specializing in Virology from Humboldt-Universität zu Berlin.